pmc.ncbi.nlm.nih.gov

Variant von Willebrand's Disease: CHARACTERIZATION OF TWO SUBTYPES BY ANALYSIS OF MULTIMERIC COMPOSITION OF FACTOR VIII/VON WILLEBRAND FACTOR IN PLASMA AND PLATELETS

Abstract

We have examined the multimeric composition of factor VIII/von Willebrand factor in plasma and platelet lysates by means of sodium dodecyl sulfate agarose electrophoresis followed by staining with 125I-labeled affinity-purified antibody. In normal plasma and platelet lysates, factor VIII/von Willebrand factor displayed 10 distinct multimers that ranged in apparent molecular weight from 0.86 to 9.9 × 106. The molecular weight difference between adjacent bands was 0.8−1.1 × 106. Larger material, not resolved into discrete bands, was also present with an average Mr of 14.5 × 106. Though the dimer (apparent Mr = 0.48 × 106) and the monomer (apparent Mr = 0.28 × 106) generated by reduction of disulfide bonds were readily identified in this system, they were not detected in normal plasma or platelets. No differences were observed between fresh plasma prepared without anticoagulant and fresh or frozen plasma anticoagulated with either citrate or heparin. “Variant” (type II) von Willebrand's disease could be divided into two subtypes. In subtype IIA, factor VIII/von Willebrand factor in plasma consisted predominantly of the five smaller multimers with traces of the sixth and seventh (Mr up to 4.5 × 106). In subtype IIB, all these multimers were easily detected and, in addition, bands of intermediate size (Mr = 8.5 × 106 and smaller) were present. In contrast, the multimeric composition of IIB platelet factor VIII/von Willebrand factor was identical to normal, whereas in subtype IIA the larger multimers were absent from platelets as well as from plasma. In subtype IIB, binding of factor VIII/von Willebrand factor to platelets occurred at lower concentrations of ristocetin than required for normal and multimers of smaller size than in normal bound. On the contrary, in subtype IIA, binding was minimal, as was true of normal factor VIII/von Willebrand factor of equivalent size. Thus, physical as well as functional differences in the two subtypes of variant von Willebrand's disease described suggest that different pathogenetic mechanisms underlie the factor VIII/von Willebrand factor abnormalities in these patients.

1318

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barber A. J., Jamieson G. A. Isolation and characterization of plasma membranes from human blood platelets. J Biol Chem. 1970 Dec 10;245(23):6357–6365. [PubMed] [Google Scholar]
  2. Counts R. B., Paskell S. L., Elgee S. K. Disulfide bonds and the quaternary structure of factor VIII/von Willebrand factor. J Clin Invest. 1978 Sep;62(3):702–709. doi: 10.1172/JCI109178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dunker A. K., Kenyon A. J. Mobility of sodium dodecyl sulphate - protein complexes. Biochem J. 1976 Feb 1;153(2):191–197. doi: 10.1042/bj1530191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fass D. N., Knutson G. J., Bowie E. J. Porcine Willebrand factor: a population of multimers. J Lab Clin Med. 1978 Feb;91(2):307–320. [PubMed] [Google Scholar]
  5. Gralnick H. R., Sultan Y., Coller B. S. Von Willebrand's disease: combined qualitative and quantitative abnormalities. N Engl J Med. 1977 May 5;296(18):1024–1030. doi: 10.1056/NEJM197705052961802. [DOI] [PubMed] [Google Scholar]
  6. Kernoff P. B., Gruson R., Rizza C. R. A variant of factor 8 related antigen. Br J Haematol. 1974 Mar;26(3):435–440. doi: 10.1111/j.1365-2141.1974.tb00484.x. [DOI] [PubMed] [Google Scholar]
  7. Koutts J., Walsh P. N., Plow E. F., Fenton J. W., 2nd, Bouma B. N., Zimmerman T. S. Active release of human platelet factor VIII-related antigen by adenosine diphosphate, collagen, and thrombin. J Clin Invest. 1978 Dec;62(6):1255–1263. doi: 10.1172/JCI109246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lawrence D. A., Weigle W. O., Spiegelberg H. L. Immunoglobulins cytophilic for human lymphocytes, monocytes, and neutrophils. J Clin Invest. 1975 Feb;55(2):368–376. doi: 10.1172/JCI107940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Legaz M. E., Schmer G., Counts R. B., Davie E. W. Isolation and characterization of human Factor VIII (antihemophilic factor). J Biol Chem. 1973 Jun 10;248(11):3946–3955. [PubMed] [Google Scholar]
  10. McConahey P. J., Dixon F. J. A method of trace iodination of proteins for immunologic studies. Int Arch Allergy Appl Immunol. 1966;29(2):185–189. doi: 10.1159/000229699. [DOI] [PubMed] [Google Scholar]
  11. Montgomery R. R., Zimmerman T. S. von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease. J Clin Invest. 1978 Jun;61(6):1498–1507. doi: 10.1172/JCI109070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mosesson M. W., Umfleet R. A. The cold-insoluble globulin of human plasma. I. Purification, primary characterization, and relationship to fibrinogen and other cold-insoluble fraction components. J Biol Chem. 1970 Nov 10;245(21):5728–5736. [PubMed] [Google Scholar]
  13. Newman J., Harris R. B., Johnson A. J. Molecular weights of antihaemophilic factor and von Willebrand factor proteins in human plasma. Nature. 1976 Oct 14;263(5578):612–613. doi: 10.1038/263612a0. [DOI] [PubMed] [Google Scholar]
  14. Nielsen T. B., Reynolds J. A. Measurements of molecular weights by gel electrophoresis. Methods Enzymol. 1978;48:3–10. doi: 10.1016/s0076-6879(78)48003-6. [DOI] [PubMed] [Google Scholar]
  15. Peake I. R., Bloom A. L., Giddings J. C. Inherited variants of factor-VIII-related protein in von Willebrand's disease. N Engl J Med. 1974 Jul 18;291(3):113–117. doi: 10.1056/NEJM197407182910301. [DOI] [PubMed] [Google Scholar]
  16. Perret B. A., Furlan M., Beck E. A. Studies on factor VIII-related protein. II. Estimation of molecular size differences between factor VIII oligomers. Biochim Biophys Acta. 1979 May 23;578(1):164–174. doi: 10.1016/0005-2795(79)90124-7. [DOI] [PubMed] [Google Scholar]
  17. Pitt-Rivers R., Impiombato F. S. The binding of sodium dodecyl sulphate to various proteins. Biochem J. 1968 Oct;109(5):825–830. doi: 10.1042/bj1090825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rock G. A., Tackaberry E. S., Palmer D. S. Factors affecting the relative distribution of high and low molecular weight forms of factor VIII. Thromb Res. 1979;14(4-5):573–587. doi: 10.1016/0049-3848(79)90113-0. [DOI] [PubMed] [Google Scholar]
  19. Ruggeri Z. M., Mannucci P. M., Bader R., Barbui T. Factor VIII-related properties in platelets from patients with von Willebrand's disease. J Lab Clin Med. 1978 Jan;91(1):132–140. [PubMed] [Google Scholar]
  20. Schmer G., Kirby E. P., Teller D. C., Davie E. W. The isolation nd characterization of bovine factor VIII (antihemophilic factor). J Biol Chem. 1972 Apr 25;247(8):2512–2521. [PubMed] [Google Scholar]
  21. Seghatchian M. J., Nilsson I. M., Homberg L., Miller-Anderson M. Molecular size distribution of factor VIII in native plasma. Thromb Res. 1979;14(4-5):589–598. doi: 10.1016/0049-3848(79)90114-2. [DOI] [PubMed] [Google Scholar]
  22. Shapiro G. A., Andersen J. C., Pizzo S. V., McKee P. A. The subunit structure of normal and hemophilic factor VIII. J Clin Invest. 1973 Sep;52(9):2198–2210. doi: 10.1172/JCI107405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Walsh P. N., Mills D. C., White J. G. Metabolism and function of human platelets washed by albumin density gradient separation. Br J Haematol. 1977 Jun;36(2):287–296. doi: 10.1111/j.1365-2141.1977.tb00649.x. [DOI] [PubMed] [Google Scholar]
  24. Weinstein M., Deykin D. Comparison of factor VIII-related von Willebrand factor proteins prepared from human cryoprecipitate and factor VIII concentrate. Blood. 1979 Jun;53(6):1095–1105. [PubMed] [Google Scholar]
  25. van Mourik J. A., Bouma B. N., LaBruyère W. T., de Graaf S., Mochtar I. A. Factor VIII, a series of homologous oligomers and a complex of two proteins. Thromb Res. 1974 Jan;4(1):155–164. doi: 10.1016/0049-3848(74)90211-4. [DOI] [PubMed] [Google Scholar]